TickerFactsScreenerDevelopers

Anika Therapeutics, Inc. (ANIK) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2008: $60.76M2009: $82.14M2010: $85.19M2011: $94.76M2012: $108.92M2013: $135.63M2014: $178.10M2015: $210.85M2016: $222.77M2017: $263.49M2018: $263.61M2019: $288.38M2020: $272.40M2021: $287.08M2022: $285.56M2023: $212.26M2024: $153.99M2025: $143.47M$143.47M
2008Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$143.47M-6.8%
2024$153.99M-27.5%
2023$212.26M-25.7%
2022$285.56M-0.5%
2021$287.08M+5.4%
2020$272.40M-5.5%
2019$288.38M+9.4%
2018$263.61M+0.0%
2017$263.49M+18.3%
2016$222.77M+5.7%
2015$210.85M+18.4%
2014$178.10M+31.3%
2013$135.63M+24.5%
2012$108.92M+14.9%
2011$94.76M+11.2%
2010$85.19M+3.7%
2009$82.14M+35.2%
2008$60.76M—